Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Open-label, Parallel-arm, Active-controlled, Multicenter Study to Evaluate Safetyand Efficacy of ALXN1850 Versus Asfotase Alfa Administered Subcutaneously in Pediatric (2 to < 12 yearsof age) Participants with Hypophosphatasia (H

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science